Showing 141 - 160 results of 1,031 for search '"Lymphatic filariasis"', query time: 0.14s Refine Results
  1. 141

    Directly observed treatment increases drug compliance in lymphatic filariasis mass drug administration by Tutik Ida Rosanti, Sugeng Juwono Mardihusodo, Wayan T. Artama

    Published 2016-08-01
    “…Mass drug administration (MDA) has been one of the strategies for lymphatic filariasis elimination. Since the start of implementation in 2011 in Pekalongan, no study on MDA acceptability has yet been done. …”
    Get full text
    Article
  2. 142

    Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis by André Filipe Pastor, Abraham Rocha, Klécia de Melo Cassemiro, Marli Tenório, Paula Melo, Maria Rosângela Grilis, Maressa Rhuama, Antonio Mauro Rezende, Osvaldo Pompilio de Melo Neto, Ernesto Marques Jr, Rafael Dhalia

    Published 2018-03-01
    “…BACKGROUND Lymphatic filariasis (LF) is a parasitic disease caused mainly by the Wuchereria bancrofti worm and that affects up to 120 million people worldwide. …”
    Get full text
    Article
  3. 143
  4. 144

    Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019 by Brady McPherson, Helen J. Mayfield, Angus McLure, Katherine Gass, Take Naseri, Robert Thomsen, Steven A. Williams, Nils Pilotte, Therese Kearns, Patricia M. Graves, Colleen L. Lau

    Published 2022-08-01
    “…Molecular xenomonitoring (MX), the detection of filarial DNA in mosquitoes using molecular methods (PCR), is a potentially useful surveillance strategy for lymphatic filariasis (LF) elimination programs. Delay in filarial antigen (Ag) clearance post-treatment is a limitation of using human surveys to provide an early indicator of the impact of mass drug administration (MDA), and MX may be more useful in this setting. …”
    Get full text
    Article
  5. 145
  6. 146

    Lymphatic filariasis transmission on Mafia Islands, Tanzania: Evidence from xenomonitoring in mosquito vectors. by Yahya A Derua, Susan F Rumisha, Bernard M Batengana, Demetrius A Max, Grades Stanley, William N Kisinza, Leonard E G Mboera

    Published 2017-10-01
    “…Lymphatic filariasis (LF) is a chronic nematode infection transmitted by mosquitoes and in sub-Saharan Africa it is caused by Wuchereria bancrofti. …”
    Get full text
    Article
  7. 147
  8. 148
  9. 149
  10. 150

    Shrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide Mapping. by Maria P Rebollo, Heven Sime, Ashenafi Assefa, Jorge Cano, Kebede Deribe, Alba Gonzalez-Escalada, Oumer Shafi, Gail Davey, Simon J Brooker, Amha Kebede, Moses J Bockarie

    Published 2015-11-01
    “…BACKGROUND:Mapping of lymphatic filariasis (LF) is essential for the delineation of endemic implementation units and determining the population at risk that will be targeted for mass drug administration (MDA). …”
    Get full text
    Article
  11. 151

    Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil. by Anita Ramesh, Mary Cameron, Kirstin Spence, Remy Hoek Spaans, Maria A V Melo-Santos, Marcelo H S Paiva, Duschinka R D Guedes, Rosangela M R Barbosa, Claudia M F Oliveira, André Sá, Claire L Jeffries, Priscila M S Castanha, Paula A S Oliveira, Thomas Walker, Neal Alexander, Cynthia Braga

    Published 2018-10-01
    “…INTRODUCTION:Molecular xenomonitoring (MX)-pathogen detection in the mosquito rather than human-is a promising tool for lymphatic filariasis (LF) surveillance. In the Recife Metropolitan Region (RMR), the last LF focus in Brazil, Culex quinquefasciatus mosquitoes have been implicated in transmitting Wuchereria bancrofti parasites. …”
    Get full text
    Article
  12. 152

    The national distribution of lymphatic filariasis cases in Malawi using patient mapping and geostatistical modelling. by Carrie Barrett, John Chiphwanya, Square Mkwanda, Dorothy E Matipula, Paul Ndhlovu, Limbikani Chaponda, Joseph D Turner, Emanuele Giorgi, Hannah Betts, Sarah Martindale, Mark J Taylor, Jonathan M Read, Louise A Kelly-Hope

    Published 2024-03-01
    “…<h4>Background</h4>In 2020 the World Health Organization (WHO) declared that Malawi had successfully eliminated lymphatic filariasis (LF) as a public health problem. Understanding clinical case distributions at a national and sub-national level is important, so essential care packages can be provided to individuals living with LF symptoms. …”
    Get full text
    Article
  13. 153
  14. 154
  15. 155
  16. 156

    Lymphatic filariasis: a method to identify subclinical lower limb change in PNG adolescents. by Susan Gordon, Wayne Melrose, Jeffrey Warner, Petra Buttner, Leigh Ward

    Published 2011-07-01
    “…Lymphedema related to lymphatic filariasis (LF) is a disabling condition that commonly manifests in adolescence. …”
    Get full text
    Article
  17. 157
  18. 158

    Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies by Prada, JM, Stolk, WA, Davis, EL, Touloupou, P, Sharma, S, Muñoz, J, Caja Rivera, RM, Reimer, LJ, Michael, E, de Vlas, SJ, Hollingsworth, TD

    Published 2021
    “…<p><strong>Background:</strong> In view of the current global coronavirus disease 2019 pandemic, mass drug administration interventions for neglected tropical diseases, including lymphatic filariasis (LF), have been halted. We used mathematical modelling to estimate the impact of delaying or cancelling treatment rounds and explore possible mitigation strategies.…”
    Journal article
  19. 159

    Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis by Taylor, MJ, von Geldern, TW, Ford, L, Hübner, MP, Marsh, K, Johnston, KL, Sjoberg, HT, Specht, S, Pionnier, N, Tyrer, HE, Clare, RH, Cook, DAN, Murphy, E, Steven, A, Archer, J, Bloemker, D, Lenz, F, Koschel, M, Ehrens, A, Metuge, HM, Chunda, VC, Chounna, PW, Njouendou, AJ, Fombad, FF, Carr, R, Morton, HE, Aljayyoussi, G, Hoerauf, A, Wanji, S, Kempf, DJ, Turner, JD, Ward, SA

    Published 2019
    “…There is an urgent global need for a safe macrofilaricide drug to accelerate elimination of the neglected tropical diseases onchocerciasis and lymphatic filariasis. From an anti-infective compound library, the macrolide veterinary antibiotic, tylosin A, was identified as a hit against Wolbachia. …”
    Journal article
  20. 160

    The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling by Ntd Modelling Consortium Lymphatic Filariasis Group

    Published 2019
    “…The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 to eliminate lymphatic filariasis (LF) as a public health problem by 1) interrupting transmission through mass drug administration (MDA) and 2) offering basic care to those suffering from lymphoedema or hydrocele due to the infection. …”
    Journal article